Natural killer cell activation via interleukin signaling

Natural killer (NK) cell activation via interleukin signaling refers to the process by which various interleukins—primarily IL‑2, IL‑12, IL‑15, and IL‑18—stimulate the activity of natural killer cells. These cytokines bind their respective receptors on the surface of NK cells and trigger intracellular signaling cascades that result in enhanced cytotoxic function against tumor or virus-infected target cells and increased secretion of pro-inflammatory cytokines such as interferon gamma (IFN‑γ)[1][2][3]. The balance between activating signals from these interleukins and inhibitory signals from other pathways determines whether an NK cell becomes fully activated. For example: "NK cells are known to be activated by Th1-type cytokines such as IL–2, –12 or –18... These [cytokines] induce proliferation...and high cytotoxicity compared with conventional mature NK cells"[1]. "Interleukin–12 plays a critical role in modulating the activities of natural killer...cells. It induces production of interferon gamma from human NK...and enhances their cytotoxicity"[2]. "Activating receptor stimulation promotes differential IL–12 signaling leading to human natural killer cell expansion..."[5] This is not a single molecular target but rather describes a complex network involving multiple molecules—interleukins themselves; their specific receptors; downstream kinases like JAK/STAT proteins; adapter proteins like DAP10/DAP12; transcription factors including NFAT/NFκB—and cellular processes that together regulate innate immunity[3][4]. Because it is not one discrete protein/receptor but instead an entire biological process/pathway involving many components at different molecular levels, it should not be considered a canonical drug target entity.

Other names

NK cell activation by interleukinsInterleukin-mediated NK cell activationCytokine-induced NK cell activation

Drugs targeting this pathway act by stimulating natural killer cells through cytokine receptors, leading to increased cytotoxicity and cytokine production (such as IFN‑γ), which enhances immune responses against tumors or infections[1][2][5].